Category of Regulated Drugs: Substances under Control
In the realm of controlled substances investigations, a specific category of sensitive compartmented information (SCI) known as CUI//SP-SUB plays a crucial role. This information is primarily obtained by the Drug Enforcement Administration (DEA) and can be found in DEA investigative reports.
If you're seeking source documents for CUI Authorities with the banner marking CU//SP-SUB as per 28 CFR 0.103, your first port of call should be the Controlled Unclassified Information (CUI) Registry maintained by the National Archives and Records Administration (NARA). This repository lists all CUI categories, marking protocols, and the source authorities (including federal regulations like 28 CFR).
By reviewing 28 CFR 0.103 directly, you can gain a better understanding of the DOJ components and specific CUI categories and markings they oversee. This regulation lists the authorities linked to the CU//SP-SUB marking, helping you identify the source legal or regulatory documents.
Your agency’s CUI Program Manager or Security Office can also provide valuable assistance. They maintain and distribute the official source documents for CUI authorities applicable locally, including any DOJ-specific Special Program substrata.
For additional guidance on implementing security controls for handling such CUI, consider consulting NIST SP 800-171. This document outlines general protective measures for CUI, though it does not list source authorities by marking. Coordination with contracting or compliance officers familiar with DFARS and CMMC standards may also be beneficial.
If you have access, the Department of Justice Foreign Affairs Manual (e.g., 12 FAM) or agency-specific manuals may provide additional context on the cryptographic and security policies tied to CUI markings like CU//SP-SUB.
In essence, the official primary source documents for CUI Authorities with CU//SP-SUB markings under 28 CFR 0.103 are found first in that CFR part itself and in the NARA CUI Registry. Agency-specific security offices are the practical intermediaries to obtain and interpret these source documents for operational use.
It's worth noting that the report does not provide information on the process for requesting access to CUI//SP-SUB documents, nor does it specify whether there are any exceptions to the use of the CU//SP-SUB banner marking for CUI//SP-SUB documents. Additionally, it remains unclear from this report whether access to these documents is restricted to specific individuals or organizations. The sanctions for unauthorized disclosure or mishandling of CUI//SP-SUB documents are also not detailed in this report.
[1] NIST SP 800-171: Protecting Controlled Unclassified Information in Nonfederal Information Systems and Organizations [2] DFARS: Defense Federal Acquisition Regulation Supplement [3] CMMC: Cybersecurity Maturity Model Certification [4] CUI Registry: https://www.archives.gov/cui/registry [5] 28 CFR 0.103: https://www.govinfo.gov/content/pkg/CFR-2021-title28-vol1/pdf/CFR-2021-title28-vol1-part0.103.pdf
To delve deeper into the health-and-wellness aspects of controlled substances, one might consult relevant literature or research publications in the field of science. For instance, reputable scientific journals such as The Lancet or Nature can provide valuable insights.
Setting up an effective security framework for managing sensitive compartmented information (SCI) like CUI//SP-SUB, as found in DEA investigative reports, can be achieved by referring to guidelines provided by organizations like the National Institute of Standards and Technology (NIST), particularly the NIST SP 800-171 document.
